英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

roughshod    音标拼音: [r'ʌfʃ'ɑd]
a. 钉有防滑蹄铁的,残酷无情的

钉有防滑蹄铁的,残酷无情的

roughshod
adj 1: (of a horse) having horseshoes with projecting nails to
prevent slipping
2: (of persons or their actions) able or disposed to inflict
pain or suffering; "a barbarous crime"; "brutal beatings";
"cruel tortures"; "Stalin's roughshod treatment of the
kulaks"; "a savage slap"; "vicious kicks" [synonym: {barbarous},
{brutal}, {cruel}, {fell}, {roughshod}, {savage}, {vicious}]
3: unjustly domineering; "incensed at the government's heavy-
handed economic policies"; "a manager who rode roughshod over
all opposition" [synonym: {heavy-handed}, {roughshod}]


请选择你想看的字典辞典：
单词字典翻译
roughshod查看　roughshod　在百度字典中的解释百度英翻中〔查看〕
roughshod查看　roughshod　在Google字典中的解释Google英翻中〔查看〕
roughshod查看　roughshod　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Tocilizumab (Actemra) - American College of Rheumatology
    Tocilizumab (Actemra) Tocilizumab (Actemra) is a biologic medication approved to treat adults with moderate to severe rheumatoid arthritis, giant cell arteritis, systemic sclerosis complicated by interstitial lung disease, and juvenile idiopathic arthritis among other diseases
  • Update on tocilizumab in rheumatoid arthritis: a narrative . . .
    Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by joint pain, swelling, and stiffness, affecting approximately 1% of the adult population Tocilizumab (TCZ), a monoclonal antibody targeting the IL-6 receptor, has emerged
  • ACTEMRA® (tocilizumab) Rheumatoid Arthritis (RA) Treatment . . .
    ACTEMRA is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
  • Tocilizumab (Actemra®) - Johns Hopkins Arthritis Center
    Tocilizumab (Actemra®) What is Tocilizumab (Actemra®)? Tocilizumab is in a class of drugs called biologics Tocilizumab is a treatment for adults with moderate to severe rheumatoid arthritis (RA), giant cell arteritis, and polyarticular and systemic juvenile idiopathic arthritis
  • Rheumatoid Arthritis (RA) Injections | ACTEMRA® (tocilizumab)
    Learn about ACTEMRA® (tocilizumab) injections for Rheumatoid Arthritis (RA) See Full Safety and Boxed Warnings for more information
  • Tocilizumab Monotherapy or Combined With Methotrexate for . . .
    Key Points Question What is the efficacy and safety profile of subcutaneous tocilizumab as monotherapy or in combination with methotrexate for patients with rheumatoid arthritis (RA)? Findings In this randomized clinical trial involving 340 patients, subcutaneous tocilizumab, both as monotherapy and combination therapy, was superior to methotrexate monotherapy in achieving an American College
  • Tocilizumab for Rheumatoid Arthritis: A Cochrane Systematic . . .
    Objective To compare the benefit and safety of tocilizumab to placebo in patients with rheumatoid arthritis (RA) Methods We searched multiple databases for published randomized or controlled clinical trials comparing benefit and safety of tocilizumab to placebo, disease-modifying antirheumatic drugs (DMARD), or other biologics For dichotomous outcomes, we calculated the relative risk, and
  • Tocilizumab | Arthritis UK
    Tocilizumab is a biological therapy for rheumatoid arthritis and juvenile idiopathic arthritis (JIA) Learn how it’s used, risks and side-effects
  • Certolizumab pegol, abatacept, tocilizumab or active . . .
    Certolizumab pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: 48-week patient-reported outcomes from the NORD-STAR trial
  • IL-6 inhibitor for the treatment of rheumatoid arthritis: A . . .
    Abstract Tocilizumab (TCZ) is an interleukin-6 (IL-6) inhibitor used for the treatment of rheumatoid arthritis (RA) It was developed in 2008, and its effectiveness is supported by evidence from all over the world based on its first decade of use Although the overall efficacy and safety profiles of TCZ are similar to those of tumor necrosis factor (TNF) inhibitors, TCZ displays certain





中文字典-英文字典  2005-2009